Aaron M. Gruver

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

Alexander Haragan, John K. Field, Michael P.A. Davies et al. · Lung Cancer · 2019 · 177 citations · Full text

Medicine, Immunology, Oncology +17

Extensive Chromosomal Instability in <i>Rad51d</i>-Deficient Mouse Cells

Phillip G. Smiraldo, Aaron M. Gruver, Joshua C. Osborn et al. · Cancer Research · 2005 · 95 citations

Life Sciences, Genetics, Molecular Genetics +17

Selective Immunohistochemical Markers to Distinguish Between Metastatic High-Grade Urothelial Carcinoma and Primary Poorly Differentiated Invasive Squamous Cell Carcinoma of the Lung

Aaron M. Gruver, Mahul B. Amin, Daniel Luthringer et al. · Archives of Pathology & Laboratory Medicine · 2012 · 82 citations

Medicine, Oncology, Pathology +17

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

Giorgio V. Scagliotti, Denis Moro‐Sibilot, Jens Kollmeier et al. · Journal of Thoracic Oncology · 2019 · 78 citations

Pharmacy, Oncology, Pharmacology +12

Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma

Zhen Wang, Bryce P. Portier, Aaron M. Gruver et al. · Journal of Molecular Diagnostics · 2013 · 73 citations

Medicine, Molecular Biology, Oncology +13